-+ 0.00%
-+ 0.00%
-+ 0.00%

GT Biopharma Reports Q2 2025 Net Loss of $1.4M, Down from $3.7M in 2024, Amid Decrease in SG&A and R&D Expenses

Reuters·08/14/2025 21:32:54

Please log in to view news